Table 1.
Baseline characteristics for training and test cohort patients.
| Clinical characteristics | Training cohort 572 (%) |
Test cohort 385 |
P |
|---|---|---|---|
| Age | 65 (56-73) | 64 (55-74) | 0.452 |
| Gender (male) | 391 (68.4) | 240 (62.3) | 0.054 |
| Smoking | 125 (21.9) | 78 (20.3) | 0.554 |
| Drinking | 71 (12.4) | 54 (14.0) | 0.468 |
| Helicobator pylori | 302 (52.8) | 195 (50.6) | 0.514 |
| Tumor differentiation (well/moderate/poor) | 99/237/236 | 56/178/151 | 0.280 |
| pT stage (1/2/3/4) | 94/60/227/191 | 48/42/160/135 | 0.413 |
| pN stage (0/1/2/3) | 149/168/110/145 | 92/140/71/82 | 0.133 |
| Metastasis | 202 (35.3) | 129 (33.5) | 0.564 |
| Chemotherapy | 280 (49.0) | 184 (47.8) | 0.725 |
| Curative/palliative | 325/247 | 201/184 | 0.160 |
| TG (mmol/L) | 1.54±1.09 | 1.50±1.14 | 0.251 |
| TC (mmol/L) | 4.43±1.04 | 4.44±1.21 | 0.202 |
| HDL-C (mmol/L) | 1.06±0.38 | 1.09±0.44 | 0.064 |
| LDL-C (mmol/L) | 2.68±0.92 | 2.62±0.82 | 0.512 |
| TG/HDL-C (mmol/L) | 1.60±1.41 | 1.62±1.38 | 0.231 |
TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG/HDL-C, TG to HDL-C ratio.
Values are medians (interquartile range) or frequencies and percentages.
Patients received treatment for either curative or palliative purposes according to the Japanese Classification of Gastric Cancer Guidelines.
Data were analyzed using χ2 test or Mann-Whitney U test.